- DAZ.online
- DAZ / AZ
- DAZ 38/2007
- Biologicals
Biologicals
Tab.: Patentablauf von Biologicals ebnet Biosimilars den Weg | ||
Handelsname |
INN |
Jahr des Patentablaufs |
Humulin® |
Human insulin |
2001 |
Cerezyme® |
Imiglucerase |
2001 |
Intron A® |
Interferon alpha-2b |
2002 |
Nutropin/Nutropin AQ® |
Somatropin |
2003 |
Avonex® |
Interferon beta-1a |
2003 |
Humatrope® |
Somatropin |
2003 |
Epogen/Procrit® |
Epoetin alfa |
2004 |
Synagis® |
Palivizumab |
2005 |
Novlin® |
Human insulin |
2005 |
Activase® |
Alteplase |
2005 |
Neupogen® |
Filgrastim |
2006 |
Albutein® |
Humanalbumin |
2006 |
Quelle: G. M. Bhopale and R. K. Nanda (2005). Recombinant DNA expression products for human therapeutic use. Current Science 89, 614-622. H Morioka (2004). Considerations about Generic Biologics. Business briefing: Pharmagenerics, 23-29
0 Kommentare
Das Kommentieren ist aktuell nicht möglich.